Valeant Pharmaceuticals International Inc (NYSE:VRX) hit a new 52-week high Tuesday as it traded at $42.22 compared with its previous 52-Week high of $42.03. Valeant Pharmaceuticals International is changing hands at $42.02 with 585,506 shares traded as of 10:12 a.m. ET. Average volume has been 2.4 million shares over the past 30 days.
Valeant Pharmaceuticals International has a market cap of $12.1 billion and is part of the health care sector and drugs industry. Shares are up 46.9% year to date as of the close of trading on Monday. Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets various pharmaceutical products primarily in the areas of neurology, dermatology, and branded generics.
Valeant Pharmaceuticals International has a market cap of $12.1 billion and is part of the health care sector and drugs industry. Shares are up 46.9% year to date as of the close of trading on Monday. Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets various pharmaceutical products primarily in the areas of neurology, dermatology, and branded generics.
No comments:
Post a Comment